Methyl Arachidonyl Fluorophosphonate structure
|
Common Name | Methyl Arachidonyl Fluorophosphonate | ||
---|---|---|---|---|
CAS Number | 188404-10-6 | Molecular Weight | 370.482 | |
Density | 1.0±0.1 g/cm3 | Boiling Point | 455.3±34.0 °C at 760 mmHg | |
Molecular Formula | C21H36FO2P | Melting Point | N/A | |
MSDS | USA | Flash Point | 229.1±25.7 °C |
Use of Methyl Arachidonyl FluorophosphonateMAFP (Methyl Arachidonyl Fluorophosphonate) is an selective, active-site directed and irreversible inhibitor of cPLA2 and iPLA2. MAFP is also a potent irreversible inhibitor of anandamide amidase. |
Name | MAFP,(5Z,8Z,11Z,14Z)-5,8,11,14-eicosatetraenyl-methylesterphosphonofluoridicacid |
---|---|
Synonym | More Synonyms |
Description | MAFP (Methyl Arachidonyl Fluorophosphonate) is an selective, active-site directed and irreversible inhibitor of cPLA2 and iPLA2. MAFP is also a potent irreversible inhibitor of anandamide amidase. |
---|---|
Related Catalog | |
Target |
cPLA2, iPLA2[1], Anandamide amidase[2] |
In Vitro | MAFP inhibits iPLA2, in a concentration-dependent manner with an IC50 of 5 μM after a 5 min preincubation at 40°C in P388D1 cells. cPLA, is a phospholipid hydrolase using the hydroxyl of serine-228 residue as its catalytic nucleophile[1]. MAFP is also an inhibitor of anandamide amidase and as a ligand for the CB1 cannabinoid receptor. MAFP demonstrates selectivity towards anandamide amidase for which it is approximately 3000 and 30000-fold more potent than it is towards chymotrypsin and trypsin, respectively. MAFP displaces [3H]CP-55940 binding to the CB1 cannabinoid receptor with an IC50 of 20 nM vs 40 nM for anandamide[2]. |
Kinase Assay | MAFP is dissolved and diluted in DMSO. To investigate the reversibility of iPLA 2 inhibition by MAFP, the P388D1 iPLA 2 is first concentrated approximately 10-fold using a Centricon-10 concentrator from Amicon. The concentrated iPLA 2 (20 μL) is then preincubated with either 80 μM MAFP in DMSO or DMSO alone (2 μL) for 5 min at 40°C. A 2 μL aliquot is removed and subsequently diluted 1500-fold into 3 mL of assay mixture containing 100 μM DPPC (200000 cpm per 50 μL assay mixture), 400 μM Triton X-100, 100 mM Hepes (pH 7.5), 5 mM EDTA, 1 mM DTT and 0.8 mM ATP. At the indicated time points, a 50 μL aliquot is removed and the remaining enzyme activity is quantified[1]. |
Cell Assay | Inhibition of anandamide amidase in cell culture is measured using approximately 1x106 Nl8TG2 intact neuroblastoma cells. Experimental cells are preincubated for 20 min in 1.5 mL medium, consisting of Fl2/DMEM with penicillin, streptomycin, gentamicin, 10% bovine calf serum, plus MAFP (1, 5, 10, 20 nM). Control cells contained no inhibitor. Arachidonoyl is then added and the incubation continued for I hr. The amount of [3H]anandamide in the cells is quantified by liquid scintillation counting of the silica scraped from the appropriate areas of the TLC plate identified by exposure to X-ray film[2]. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 455.3±34.0 °C at 760 mmHg |
Molecular Formula | C21H36FO2P |
Molecular Weight | 370.482 |
Flash Point | 229.1±25.7 °C |
Exact Mass | 370.243683 |
PSA | 36.11000 |
LogP | 7.44 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.474 |
Storage condition | 2-8℃ |
Hazard Codes | F: Flammable;Xi: Irritant; |
---|---|
Risk Phrases | R11 |
Safety Phrases | 16-26-29-33 |
RIDADR | UN 1231 3/PG 2 |
Methyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraen-1-ylphosphonofluoridate |
Methyl (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraen-1-ylphosphonofluoridate |
Phosphonofluoridic acid, P-[(5Z,8Z,11Z,14Z)-5,8,11,14-eicosatetraen-1-yl]-, methyl ester |
Methyl Arachidonyl Fluorophosphonate |
MAPF,Phosphonofluoridic acid,methyl-5Z,8Z,11Z,14Z-eicosatetraenyl ester |
Phosphonofluoridicacid |
5Z,8Z,11Z,14Z-EICOSATETRAENYL-PHOSPHONOFLUORIDIC ACID,METHYL ESTER |
MAPF |
METHYLPHOSPHONOFLUORIDIC ACID 5,8,11,14-EICOSATETRAENYL ESTER |
METHYL-5Z,8Z,11Z,14Z-EICOSATETRAENYL ESTER PHOSPHONOFLUORIDIC ACID METHYL ACETATE |
MAFP |